Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pilar Escribano

Showing results (181-190 of 270) with videos related to

Pageof 27
Sort By:
The European Respiratory Journal|August 9, 2019
Efficacy and safety of ralinepag, a novel oral IP agonist, in PAH patients on mono or dual background therapy: results from a phase 2 randomised, parallel group, placebo-controlled trialFernando Torres, Harrison Farber, Arsen Ristic, et al.
Revista Espanola De Cardiologia|April 12, 2003
[Treatment of HIV-associated pulmonary hypertension with treprostinil]Luis Cea-Calvo, Pilar Escribano Subías, Rocío Tello de Menesses, et al.
Pulmonary Circulation|October 14, 2022
The impact of COVID-19 pandemic on pulmonary hypertension: What have we learned?Williams Hinojosa, María José Cristo-Ropero, Alejandro Cruz-Utrilla, et al.
Antimicrobial Agents and Chemotherapy|April 26, 2017
Candida guilliermondii Complex Is Characterized by High Antifungal Resistance but Low Mortality in 22 Cases of CandidemiaLaura Judith Marcos-Zambrano, Mireia Puig-Asensio, Felipe Pérez-García, et al.
Revista Espanola De Cardiologia (English Ed.)|July 14, 2020
Chronic thromboembolic pulmonary hypertension in Spain: a decade of changePaula Martínez-Santos, María Teresa Velázquez-Martín, Joan Albert Barberá, et al.
Mycoses|January 29, 2024
Clonal spread of fluconazole-resistant C. parapsilosis in patients admitted to a referral hospital located in Burgos, Spain, during the COVID-19 pandemicMaría de Los Ángeles Mantecón-Vallejo, Aina Mesquida, María de Valle Ortiz, et al.
International Journal of Cardiology|August 24, 2025
Prognostic value of longitudinal QTc interval analysis in pulmonary arterial hypertensionWilliams Hinojosa, Maite Velázquez-Martin, Maria Lorena Coronel, et al.
Revista Espanola De Cardiologia (English Ed.)|July 13, 2017
Variable Expressivity of a Founder Mutation in the EIF2AK4 Gene in Hereditary Pulmonary Veno-occlusive Disease and Its Impact on SurvivalPaula Navas Tejedor, Julián Palomino Doza, Jair Antonio Tenorio Castaño, et al.
Frontiers in Medicine|May 17, 2021
Novel <i>TNIP2</i> and <i>TRAF2</i> Variants Are Implicated in the Pathogenesis of Pulmonary Arterial HypertensionShaun Pienkos, Natalia Gallego, David F Condon, et al.
European Journal of Heart Failure|March 9, 2026
Risk stratification for adult patients with pulmonary arterial hypertension associated with congenital heart disease. A scientific statement of the ESC Working Group on Pulmonary Circulation & Right Ventricular Function, the ESC Working Group on Adult Congenital Heart Disease, and the Association of Cardiovascular Nursing & Allied Professions of the ESCMichele D'Alto, George Giannakoulas, Jamil Aboulhosn, et al.
Pageof 27

Showing results (181-190 of 270) with videos related to

Sort By:
Pageof 27
The European Respiratory Journal|August 9, 2019
Efficacy and safety of ralinepag, a novel oral IP agonist, in PAH patients on mono or dual background therapy: results from a phase 2 randomised, parallel group, placebo-controlled trialFernando Torres, Harrison Farber, Arsen Ristic, et al.
Revista Espanola De Cardiologia|April 12, 2003
[Treatment of HIV-associated pulmonary hypertension with treprostinil]Luis Cea-Calvo, Pilar Escribano Subías, Rocío Tello de Menesses, et al.
Pulmonary Circulation|October 14, 2022
The impact of COVID-19 pandemic on pulmonary hypertension: What have we learned?Williams Hinojosa, María José Cristo-Ropero, Alejandro Cruz-Utrilla, et al.
Antimicrobial Agents and Chemotherapy|April 26, 2017
Candida guilliermondii Complex Is Characterized by High Antifungal Resistance but Low Mortality in 22 Cases of CandidemiaLaura Judith Marcos-Zambrano, Mireia Puig-Asensio, Felipe Pérez-García, et al.
Revista Espanola De Cardiologia (English Ed.)|July 14, 2020
Chronic thromboembolic pulmonary hypertension in Spain: a decade of changePaula Martínez-Santos, María Teresa Velázquez-Martín, Joan Albert Barberá, et al.
Mycoses|January 29, 2024
Clonal spread of fluconazole-resistant C. parapsilosis in patients admitted to a referral hospital located in Burgos, Spain, during the COVID-19 pandemicMaría de Los Ángeles Mantecón-Vallejo, Aina Mesquida, María de Valle Ortiz, et al.
International Journal of Cardiology|August 24, 2025
Prognostic value of longitudinal QTc interval analysis in pulmonary arterial hypertensionWilliams Hinojosa, Maite Velázquez-Martin, Maria Lorena Coronel, et al.
Revista Espanola De Cardiologia (English Ed.)|July 13, 2017
Variable Expressivity of a Founder Mutation in the EIF2AK4 Gene in Hereditary Pulmonary Veno-occlusive Disease and Its Impact on SurvivalPaula Navas Tejedor, Julián Palomino Doza, Jair Antonio Tenorio Castaño, et al.
Frontiers in Medicine|May 17, 2021
Novel <i>TNIP2</i> and <i>TRAF2</i> Variants Are Implicated in the Pathogenesis of Pulmonary Arterial HypertensionShaun Pienkos, Natalia Gallego, David F Condon, et al.
European Journal of Heart Failure|March 9, 2026
Risk stratification for adult patients with pulmonary arterial hypertension associated with congenital heart disease. A scientific statement of the ESC Working Group on Pulmonary Circulation & Right Ventricular Function, the ESC Working Group on Adult Congenital Heart Disease, and the Association of Cardiovascular Nursing & Allied Professions of the ESCMichele D'Alto, George Giannakoulas, Jamil Aboulhosn, et al.
Pageof 27